Hydroxocobalamin Alternova

Hydroxocobalamin, the active ingredient in Hydroxocobalamin Alternova, is a Vitamin B12 (cobalamin) preparation presented as an injectable solution for intramuscular use. It treats vitamin B12 deficiency, pernicious anemia, and can serve as an antidote for cyanide poisoning in appropriate patients.

GNH USA supplies Hydroxocobalamin Alternova as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hydroxocobalamin Alternova is used to address disorders related to vitamin B12 deficiency and cyanide toxicity.

- Vitamin B12 deficiency: restores normal B12 levels and supports hematopoiesis. - Pernicious anemia: corrects anemia by providing bioavailable cobalamin. - Cyanide poisoning: binds cyanide to form cyanocobalamin, facilitating detoxification and excretion.

Hydroxocobalamin Alternova may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Injection site pain or erythema. - Mild headache. - Transient flushing or warmth. - Nausea or mild gastrointestinal upset. - Low‑grade fever. - Dizziness.

Serious or Rare Side Effects: - Anaphylactic reaction or severe hypersensitivity. - Hypotension or cardiovascular collapse. - Severe rash or Stevens‑Johnson syndrome. - Hemolytic anemia. - Acute renal impairment. - Pulmonary edema.

When using Hydroxocobalamin Alternova, consider the following precautions.

- Renal impairment: monitor patients with severe kidney disease. - Pregnancy: use only if clearly needed after risk‑benefit assessment. - Allergy: avoid in patients with known hypersensitivity to cobalamin or formulation components. - Concurrent cyanide exposure: ensure appropriate dosing and monitoring. - Drug interactions: review concomitant medications for potential effects on B12 metabolism. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Hydroxocobalamin may interact with several medicines; categorize the significance.

Major Interactions (Avoid): - Nitrous oxide anesthesia: can exacerbate functional B12 deficiency. - Methotrexate: may increase risk of hematologic toxicity. - Cytotoxic chemotherapy agents: may require dose adjustments.

Moderate Interactions (Monitor Closely): - Metformin: may reduce B12 absorption, monitor levels. - Proton pump inhibitors: may affect B12 status, periodic assessment advised. - Anticonvulsants (e.g., phenytoin): may interfere with B12 metabolism.